Stein Steven H's Form 4 filing
Incyte Corp (INCY) · filed Dec 3, 2025
- Accession no.
- 0001673776-25-000006
- Filed
- Dec 3, 2025
- Trade date
- Dec 1-2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stein Steven HCIK 0001673776 | Officer (EVP & Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,559 | $102.96 | −$263,474.64 | 100,327 | Direct | |
| Dec 1, 2025 | Common Stock | FTax withholdingDisposed | −17,093 | $102.04 | −$1,744,169.72 | 83,234 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −20,105 | $102.51 | −$2,060,963.55 | 63,129 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.